Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome

Código QR

Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome

Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) affects approximately 1% of the general population. It is a chronic, disabling, multi-system disease for which there is no effective treatment. This is probably related to the limited knowledge about its origin. Here, we summarized the c...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Manuel Ruiz-Pablos, Bruno Paiva, Rosario Montero-Mateo, Nicolas Garcia, Aintzane Zabaleta
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	chronic fatigue syndrome myalgic encephalomyelitis EBV EBNA-1 HLA-II alleles cancer CD4+ CTL Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/40b36b3f5a574fb7adff4134fe44b6a4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
por: Iñigo Murga, et al.
Publicado: (2021)

An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Klaus J. Wirth, et al.
Publicado: (2021)

Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients
por: Nguyen,T., et al.
Publicado: (2016)

Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Helen Brownlie, et al.
Publicado: (2021)

Associations Between Psychological and Immunological Variables in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review
por: Emilie F. W. Raanes, et al.
Publicado: (2021)

Fatigue biomedicine, health & behavior.

Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP<sub>2</sub> in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Stanley Du Preez, et al.
Publicado: (2021)

Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk
por: Fabienne Läderach, et al.
Publicado: (2021)

Chronic Fatigue Syndrome: A Case Report Highlighting Diagnosing and Treatment Challenges and the Possibility of Jarisch–Herxheimer Reactions If High Infectious Loads Are Present
por: Rachel K. Straub, et al.
Publicado: (2021)

mapMECFS: a portal to enhance data discovery across biological disciplines and collaborative sites
por: Ravi Mathur, et al.
Publicado: (2021)

Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
por: Mark Manzano, et al.
Publicado: (2020)

PRESENCIA DEL MARCADOR LMP-1 DEL VIRUS EPSTEIN-BARR EN LINFOMAS DE CANINOS
por: L. C. Veloza, et al.
Publicado: (2017)

Air-Liquid Interface System To Understand Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma
por: Sharon E. Hopcraft, et al.
Publicado: (2018)

Identifying Epstein–Barr virus peptide sequences associated with differential IgG antibody response
por: Anna E. Coghill, et al.
Publicado: (2022)

Detecting and Monitoring Porcine Hemagglutinating Encephalomyelitis Virus, an Underresearched Betacoronavirus
por: Juan Carlos Mora-Díaz, et al.
Publicado: (2020)

Epstein-Barr Virus-Associated Carcinoma of the Larynx: A Systematic Review with Meta-Analysis
por: Marcos Antonio Pereira de Lima, et al.
Publicado: (2021)

Inmunohistoquímica en un caso de encefalitis por virus de Epstein Barr
por: Calore,Edenilson E, et al.
Publicado: (2012)

Interplay between IL-10, IFN-γ, IL-17A and PD-1 Expressing EBNA1-Specific CD4<sup>+</sup> and CD8<sup>+</sup> T Cell Responses in the Etiologic Pathway to Endemic Burkitt Lymphoma
por: Catherine S. Forconi, et al.
Publicado: (2021)

Reevaluating the Impact of Epstein-Barr Virus Noncoding RNAs on the Interferon Response
por: Eain A. Murphy
Publicado: (2021)

Comparative analysis of HLA II allele and genotype frequency distribution in patients with type 1 diabetes mellitus and autoimmune thyroiditis
por: Ekaterina Alexandrovna Repina, et al.
Publicado: (2013)

Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality
por: Sara R. Selitsky, et al.
Publicado: (2018)

Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells
por: Takaya Ichikawa, et al.
Publicado: (2018)

Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle
por: Mark R. Eichelberg, et al.
Publicado: (2019)

Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’?
por: Emily Wood, et al.
Publicado: (2021)

Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival
por: Jin Hua Liang, et al.
Publicado: (2021)

Competitive Endogenous RNA Landscape in Epstein-Barr Virus Associated Nasopharyngeal Carcinoma
por: Xiandong Lin, et al.
Publicado: (2021)

FUCTIONAL OUTCOME OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN CHILDREN
por: Muhammad Zia Ur Rehman, et al.
Publicado: (2018)

Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
por: L. N. Bubnova, et al.
Publicado: (2021)

HLA diversity in the Russian population assessed by next generation sequencing
por: E. G. Khamaganova, et al.
Publicado: (2021)

Breast cancer immunophenotype and its relationship with haematopoiesis
por: Denis A. Ryabchikov, et al.
Publicado: (2021)

BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon <italic toggle="yes">De Novo</italic> Infection
por: Natsuno Konishi, et al.
Publicado: (2018)

DYNAMICS OF CIRCULATING AND EXPRESSED CYTOKINES UPON INDUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
por: Yu. L. Zhitnukhin, et al.
Publicado: (2014)

HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
por: Geok Wee Tan, et al.
Publicado: (2021)

High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.
por: Ekua W Brenu, et al.
Publicado: (2014)

Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma
por: Osman Cen, et al.
Publicado: (2018)

Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires
por: Anna Gil, et al.
Publicado: (2020)

Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
por: Ghareghani Majid, et al.
Publicado: (2021)

Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation
por: Suzan Fares, et al.
Publicado: (2019)

Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis
por: Asma Hassani, et al.
Publicado: (2021)

Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
por: Elham Ahmadi, et al.
Publicado: (2021)